BELLEVUE GROUP AG – Viridian Therapeutics, Inc. Transaction History
BELLEVUE GROUP AG portfolio value:
$946,000
portfolio value
BELLEVUE GROUP AG quarter portfolio value change:
+77.27%
quarter
Viridian Therapeutics, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -5.92% | -2.9K shares | 379K | $20.51 | 46.1K |
Q2 2022 | share | Increase | 0.00% | 49K shares | 567K | $11.57 | 49K |